anti-CD19 antibody
Mar 28, 2018
Business Cocktail
Novo Holdings optimistic about investments in life sciences Novo Holdings is planning to increase its investment in early & late stage biotechs. Its focus will be mainly in the U.S. and Europe. They are optimistic about the investment in life-science companies with their past experience. NMD gets USD 47 million...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
